Suchergebnisse - "Halpin, David M G"

PubPharm (18)

1

Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease : Post hoc analysis of the IMPACT trial

enthalten in: Respirology (Carlton, Vic.) | 2022

von Thompson, P. | Criner, G. | Dransfield, M. | +9

CommentIn: Respirology. 2022 Dec;27(12):1006-1007. - PMID 36031687

2

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD : IMPACT trial post hoc analysis

enthalten in: Respiratory medicine | 2022

von Bardsley, S. | Criner, G. | Halpin, D. | +12

3

Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid Dose

enthalten in: The journal of allergy and clinical immunology. In practice | 2022

von Domingo, C. | Maspero, J. | Castro, M. | +12

4

Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthma

enthalten in: The European respiratory journal | 2021

von Corren, J. | Katelaris, C. | Castro, M. | +9

5

Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT

enthalten in: Annals of the American Thoracic Society | 2021

von Dransfield, M. | Crim, C. | Criner, G. | +13

6

InforMing the PAthway of COPD Treatment (IMPACT) trial : fibrinogen levels predict risk of moderate or severe exacerbations

enthalten in: Respiratory research | 2021

von Singh, D. | Criner, G. | Dransfield, M. | +12

7

Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD : A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial

enthalten in: Chest | 2021

von Hanania, N. | Mannino, D. | Criner, G. | +12

CommentIn: Chest. 2021 Mar;159(3):895-896. - PMID 33678268

8

The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial

enthalten in: American journal of respiratory and critical care medicine | 2020

von Han, M. | Criner, G. | Dransfield, M. | +11

CommentIn: Am J Respir Crit Care Med. 2020 Nov 1;202(9):1202-1204. - PMID 32758097

9

Composite endpoints in COPD : clinically important deterioration in the UPLIFT trial

enthalten in: Respiratory research | 2020

von Rabe, K. | Halpin, D. | Han, M. | +5

10

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

enthalten in: American journal of respiratory and critical care medicine | 2020

von Lipson, D. | Crim, C. | Criner, G. | +17

CommentIn: Am J Respir Crit Care Med. 2020 Jun 15;201(12):1463-1464. - PMID 32212973